Pentostatin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Pentostatin Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 08/27/2026. Reported reason: Other
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-0801-01
- Dosage Form
- Injection
- Presentation
- Nipent, Injection, 10 mg, single dose vial (NDC 0409-0801-01)
- Initial Posting
- 08/27/2026
- Revised Date
Reason
Other